Hepatitis C reinfection in former and active injecting drug users in Belgium

Hepatitis C reinfection in former and active injecting drug users in Belgium

Abstract Background There is currently no systematic screening for hepatitis C (HCV) reinfection in people who inject drugs (PWID) after treatment in Belgium. However, in a recent meta-analysis, the overall HCV reinfection rate was 5.9/100 person-years (PY) among PWID. Accordingly, this study was un...

Full description

Bibliographic Details
Main Authors: Dana Busschots, Rob Bielen, Özgür M. Koc, Leen Heyens, Rita Verrando, Chantal de Galocsy, Christophe Van Steenkiste, Frederik Nevens, Håvard Midgard, Olav Dalgard, Geert Robaeys
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Harm Reduction Journal
Subjects:
Reinfection
Hepatitis C virus
People who inject drugs
Direct-acting antivirals
Online Access:https://doi.org/10.1186/s12954-021-00552-x

Internet

https://doi.org/10.1186/s12954-021-00552-x

Similar Items